Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 -137.1%
March 31, 2026 -86.00%
December 31, 2025 -984.9%
September 30, 2025 84.50%
June 30, 2025 -139.6%
March 31, 2025 -19.70%
December 31, 2024 6.99%
September 30, 2024 69.89%
June 30, 2024 75.91%
March 31, 2024 75.66%
December 31, 2023 75.24%
September 30, 2023 73.09%
June 30, 2023 77.36%
March 31, 2023 81.93%
December 31, 2022 83.41%
September 30, 2022 82.61%
June 30, 2022 85.66%
March 31, 2022 82.75%
December 31, 2021 85.90%
September 30, 2021 85.40%
June 30, 2021 87.32%
March 31, 2021 85.49%
December 31, 2020 92.46%
September 30, 2020 90.35%
June 30, 2020 88.89%
Date Value
March 31, 2020 88.57%
December 31, 2019 84.33%
September 30, 2019 85.25%
June 30, 2019 80.67%
March 31, 2019 79.23%
December 31, 2018 78.60%
September 30, 2018 78.02%
June 30, 2018 78.57%
March 31, 2018 61.63%
December 31, 2017 73.66%
September 30, 2017 80.69%
June 30, 2017 77.50%
March 31, 2017 63.74%
December 31, 2016 81.48%
September 30, 2016 78.94%
June 30, 2016 81.99%
March 31, 2016 78.48%
December 31, 2015 57.78%
September 30, 2015 75.05%
June 30, 2015 71.23%
March 31, 2015 78.05%
December 31, 2014 83.95%
September 30, 2014 76.74%
June 30, 2014 78.86%
March 31, 2014 83.51%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Swedencare AB 7.63%
Camurus AB 92.70%
Moberg Pharma AB 65.36%
Infant Bacterial Therapeutics AB --
AstraZeneca PLC 76.09%

Gross Profit Margin (Quarterly) Related Metrics